Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available
Posted on: Tuesday, 27 January 2009, 07:00 CST
Allergy Product in New Bubble Gum Flavor for Ages Two Years and Older
FT.
"The new sugar-free, dye-free children's allergy product offers the allergy relief of ZYRTEC(R) that parents have relied on for years, but without the addition of corn syrup or food dyes," said Rohinish Hooda, Vice President of Marketing, Upper Respiratory, McNeil Consumer Healthcare. "Children's ZYRTEC(R) Allergy Bubble Gum Syrup is an important addition to our pediatric portfolio to help parents manage their child's indoor and outdoor allergy symptoms."
Children's ZYRTEC(R) Allergy Bubble Gum Syrup, which is available in a convenient plastic bottle, received approval from the Food and Drug Administration in
About Allergies
More than 36 million Americans suffer from indoor and outdoor allergic rhinitis, also known as upper respiratory allergies. Up to 40 percent of children are affected by allergic rhinitis. In fact, on any given day, an estimated 10,000 American children miss school because of allergic rhinitis, for an annual total of two million lost school days. Allergies are caused when a person's immune system overreacts to normally harmless substances. These substances are often referred to as triggers. People can encounter indoor and outdoor allergy triggers anytime throughout the year that can lead to allergy symptoms. For children with allergies, the change of the seasons, sports, and even the school building itself can trigger symptoms like sneezing, runny nose and itchy-watery eyes.
About ZYRTEC(R)
ZYRTEC(R) is an antihistamine that helps block the action of histamine in the body. ZYRTEC(R) helps provide 24 hour relief of indoor and outdoor upper respiratory allergy symptoms including symptoms of sneezing, runny nose, and itchy-watery eyes. These symptoms can be caused by allergy triggers such as dust, mold and pet dander, tree pollen, weeds and grasses. ZYRTEC(R) offers a full line of products for adults, including ZYRTEC(R) tablets and ZYRTEC-D(R), as well as children. For more information about full line of ZYRTEC(R) products, visit www.zyrtec.com.
About McNeil Consumer Healthcare
McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., a subsidiary of Johnson & Johnson, markets a broad range of well-known and trusted over-the-counter (OTC) products. McNeil Consumer Healthcare is most widely recognized for the complete line of TYLENOL(R) acetaminophen products, the leading pain reliever brand in the adult and pediatric categories. The TYLENOL(R) product line consists of hundreds of products across a variety of pain categories including: arthritis pain, pain with accompanying sleeplessness and upper respiratory. Other McNeil Consumer Healthcare brands include BENADRYL(R) allergy medicine; IMODIUM(R) A-D anti-diarrheal; MOTRIN(R) IB; PediaCare(R) upper respiratory medicines for children; ROLAIDS(R) antacid products; ST. JOSEPH(R) Adult Regimen Aspirin; and SUDAFED(R) and SUDAFED PE(R) nasal decongestants.
CONTACTS: Teresa Panas Kathryn Ritzinger McNeil Consumer Healthcare Cohn & Wolfe (908) 904-3198 (212) 537-8217 tpanas@its.jnj.com kathryn.ritzinger@cohnwolfe.comSOURCE McNeil Consumer Healthcare
Source: PR Newswire
Related Articles
- /C O R R E C T I O N -- GlaxoSmithKline Consumer Healthcare/
- Nutrition 21's President and CEO, Elected to the Consumer Healthcare Products Association Board
- GlaxoSmithKline Consumer Healthcare to Reach 85 Percent of the World's Smokers with Quit Aids
- YMCA of the USA and McNeil Consumer Healthcare Partner to Promote Health for Older Adults
- Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children Under Two Years of Age
- Statement From the Consumer Healthcare Products Association on the SAMHSA Findings on Cough Medicine Abuse
- Statement From the Consumer Healthcare Products Association on Today's FDA Advisory Committee Meeting on the Efficacy of Phenylephrine in the 10 Mg Oral Dose
- Johnson & Johnson Completes Acquisition of Pfizer Consumer Healthcare
- FDA Joint Advisory Committee Sets Date to Review GlaxoSmithKline Consumer Healthcare's Proposal for Orlistat 60(Mg) Capsules for Over-the-Counter Use
User Comments (0)

RSS Feeds